Literature DB >> 6334579

Inhibition of interleukin-2 production by adherent cell factors from lepromatous leprosy patients.

I Nath, J Jayaraman, M Sathish, L K Bhutani, A K Sharma.   

Abstract

Twenty-four hour supernatants (MoF) were obtained from monocyte rich 2 h adherent cells of 19 leprosy patients and four healthy contacts. MoF from borderline and lepromatous patients produced 52-61% inhibition of human interleukin-2 (IL-2) production by a PHA conditioned T cell line (Jurkat). Non-adherent cell supernatants and MoF from tuberculoid and healthy individuals had little effect on IL-2 production. The suppression effected by MoF was in the first 12 h of initiation of PHA stimulated Jurkat cell cultures. Suppressive MoF did not interfere with (1) IL-2 release, (2) IL-2 utilization by Con A-induced T cell blasts or (3) constitutive proliferation of Jurkat cells. Such MoF were released spontaneously from adherent cells of bacilliferous leprosy patients but required in vitro antigen triggering in long term treated lepromatous patients. It is possible that the unresponsiveness associated with lepromatous leprosy is related to the inhibition of IL-2 production by suppressive factors, thereby, preventing the further expansion of antigen reactive T cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334579      PMCID: PMC1577108     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors.

Authors:  J Andersson; K O Grönvik; E L Larsson; A Coutinho
Journal:  Eur J Immunol       Date:  1979-08       Impact factor: 5.532

Review 2.  Immunological aspects of leprosy--present status.

Authors:  T Godal
Journal:  Prog Allergy       Date:  1978

Review 3.  Mediators of immunity: lymphokines and monokines.

Authors:  R E Rocklin; K Bendtzen; D Greineder
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

4.  The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.

Authors:  I Nath; R Singh
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

5.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

6.  Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients.

Authors:  V Mehra; L H Mason; W Rothman; E Reinherz; S F Schlossman; B R Bloom
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

7.  Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.

Authors:  I Nath; M Sathish; T Jayaraman; L K Bhutani; A K Sharma
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

8.  Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.

Authors:  I Nath; J J Van Rood; N K Mehra; M C Vaidya
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

9.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo.

Authors:  C Hardt; M Röllinghoff; K Pfizenmaier; H Mosmann; H Wagner
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  6 in total

1.  Accessory cell heterogeneity in lepromatous leprosy; dendritic cells and not monocytes support T cell responses.

Authors:  A Mittal; R S Mishra; I Nath
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

2.  Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae.

Authors:  N Misra; A Murtaza; B Walker; N P Narayan; R S Misra; V Ramesh; S Singh; M J Colston; I Nath
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

3.  Interleukin 2 (IL 2) inhibitor in rheumatoid synovial fluid: correlation with prognosis and soluble IL 2 receptor levels.

Authors:  P Miossec; M Elhamiani; B Chichehian; A D D'Angeac; J Sany; M Hirn
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

4.  Regulatory role of FcR+ and FcR- monocyte subsets in Mycobacterium leprae-induced lymphoproliferative response in vitro.

Authors:  S Ohkawa; L N Martin; Y Fukunishi; B J Gormus
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

5.  Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type.

Authors:  H K Prasad; R S Mishra; I Nath
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

6.  Elevated IL-6R on CD4+ T cells promotes IL-6 driven Th17 cell responses in patients with T1R leprosy reactions.

Authors:  Chaman Saini; Rupesh K Srivastava; Mohd Tarique; Santosh Kurra; Neena Khanna; V Ramesh; Alpana Sharma
Journal:  Sci Rep       Date:  2020-09-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.